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It is well known that dyslipidemia is a major risk factor for coro-
nary heart disease and stroke, which are currently the leading cau-
ses of death in Korea. Dyslipidemia refers to the abnormal amount 
or imbalance of lipids in the blood, and its clinically important types 
include elevated total cholesterol, elevated triglycerides, elevated 
low density lipoprotein-cholesterol (LDL-C), and decreased high 
density lipoprotein-cholesterol (HDL-C) levels. Among the major 
types of blood cholesterol, LDL-C is the most extensively studied in 
association with the risk of cardiovascular disease. Numerous obser-
vational and experimental studies have confirmed that a high LDL-
C level is strongly associated with the risk of cardiovascular disease, 
and lipid-lowering medication and lifestyle modification can effec-
tively lower cardiovascular disease incidence and mortality.1-5) In Ko-
rea, dyslipidemia did not cause great public interest until the 1990s 
because of the relatively low incidence of coronary heart disease 
prior to 1990. Over the last few decades, obesity has become more 
prevalent in Korea due to increasing consumption of high-fat diets 
and decreasing physical activity,6) and has raised concerns about 
dyslipidemia. The Korea National Health and Nutrition Examination 
Survey (KNHANES) measured blood levels of total cholesterol, trigly-
cerides, and HDL-C in national representative samples since 1998. 
Thereafter the KNHANES official reports and independent research 
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papers have reported the prevalence of dyslipidemia or metabolic 
syndrome.6-19) Although LDL-C is a strong predictor of cardiovascu-
lar disease and most lipid-lowering drugs are targeted to reduce LDL-
C level, there is only limited information about the prevalence and 
management indexes of high LDL-C in the Korean population. A pos-
sible reason for the lack of information on LDL-C level is that com-
mon criteria for metabolic syndrome include triglycerides and HDL-
C levels but not LDL-C level.20)21) Another reason is that the KNHA-
NES and many other large population studies do not directly meas-
ure LDL-C. 
In this issue of the Korean Circulation Journal, Choi et al.22) report 
on the prevalence, awareness, and treatment rates of high LDL-C in 
Korean adults based on the 2005 KNHANES data. According to their 
estimation, 6.6% of Korean adults aged 20-79 years had LDL-C le-
vel of 160 mg/dL or higher. They estimated that 10.0% of Korean 
adults had LDL-C levels that should be lowered by pharmacologic 
treatment and 19.9% had LDL-C levels which needed therapeutic 
lifestyle modifications,22) according to the Third Report of the Na-
tional Cholesterol Education Program Expert Panel on Detection, 
Evaluation, and Treatment of High Blood Cholesterol in Adults.20) 
They also showed that only a small proportion of people with high 
LDL-C were aware of their condition and were currently under tr-
eatment. These estimations inform us about the burden of high LDL-
C as well as our current status in preventive therapy for individuals 
at high cardiovascular risk. This study provides very useful informa-
tion, especially because it is the first national demonstration of rep-
resentative data on the prevalence, awareness, and treatment rates 
of elevated LDL-C. However, we also need to be cautious when we 
interpret these estimations and compare them with others. Preva-
lence of a certain disease can be differently estimated for a variety 
of reasons. Although differences in the study population and study 
design are the biggest causes of inconsistent prevalence estimation, 
even studies analyzing the same dataset can produce inconsistent 
disease prevalence.23) Potential causes of inconsistent prevalence 
estimates may include different diagnostic criteria, different exclu-
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sion criteria, and different statistical methods. The distribution of 
lipid levels in Choi et al.22) report was not equal to the distribution 
in the 2005 KNHANES official report. The most probable causes of 
this include different exclusion criteria and different statistical me-
thods, especially in dealing with sampling weights. The paper desc-
ribed exclusion criteria for their analysis but did not mention how 
sampling weights were considered. The KNHANES applied unequal 
selection probabilities and assigned different sampling weights to 
each sample unit. Sampling units and their weights in the KNHANES 
were related to geographic regions and residential types. Although 
socioeconomic factors are not major determinants of dyslipidemia, 
they can be related with awareness and treatment of this condition. 
In addition, the effects of sampling weights can be greater when an-
alyzing subgroup data rather than an entire dataset, because of sm-
aller sample size. Calculation of LDL-C level can be another issue, 
as the authors already acknowledged. Calculated LDL-C levels are 
underestimated when compared with directly measured levels, and 
the discrepancies between two methods vary by sex, age, fasting 
hours, and triglyceride levels.24)25) Thus the prevalence, awareness, 
and treatment rates can be affected by the methods of LDL-C mea-
surement. It is difficult to determine which study produces the best 
estimate of disease prevalence, because each study involves unique 
objectives and rationales for the methodologies employed. Instead 
we should consider the potential causes of different estimates when 
reporting and interpreting research data on disease prevalence, aw-
areness, and treatment rates. 
The KNHANES datasets are a useful source for understanding dis-
tributions of lipid levels in the Korean population. Direct measure-
ment of LDL-C can be adopted in the KNHANES considering the im-
portance of LDL-C in the diagnosis and treatment of dyslipidemia 
and the prevention of cardiovascular disease. More studies based on 
the KNHANES and other population datasets are required to un-
derstand where we stand and where we are going in the manage-
ment of dyslipidemia. Meanwhile, we should be aware of the poten-
tial causes of different estimates when we report and compare po-
pulation data on LDL-C level. 
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